Posted by helpme on June 30, 2006, at 17:27:22
In reply to Re: EMSAM doses too low to effect depression ? » notfred, posted by Jakeman on June 11, 2006, at 22:11:09
You believe the marketeers at the pharmaceutical companies? You think they are out to do favors for humanity or make money with novel products and clever spins? Ever notice they like to specialize in drugs for CHRONIC conditions?> What you are saying is in opposition to the studies conducted my Somerset and others which indicate that transdermal delivery by-passes first-pass metabolism resulting in higher exposure to selegline and less dietary restrictions as well as less exposure to metabolites. How are they wrong?
>
> Warm regards, Jake
>
> MSAM does not inhibit MAO-A at lower doses. This alone and not its transdermal delivery system accounts for the lack of dietary restrictions.
> >
poster:helpme
thread:655515
URL: http://www.dr-bob.org/babble/20060623/msgs/662992.html